RNA

Ensuring genetic databases are representative

McGill researchers collaborate on national initiatives to address the health inequities faced by Canadian Indigenous populations when accessing genomic technologies for the diagnosis of genetic diseases. 

RNA

A commitment to participatory research to address Indigenous health gaps

McGill is committed to an action plan for building healthier futures for Indigenous (First Nations, Inuit and Métis) peoples living in Canada.

RNA

How mRNA vaccines might change the course of medical history

RNA

Developing a strategy to combat rare diseases

Together with Montréal InVivo, the Life Sciences and Health Technologies (LSHT) cluster of Greater Montréal, McGill is pioneering research in Canada in the in the field of rare diseases (French only).

RNA

McGill joins Moderna in battle against global health threats

McGill is the first university in Canada to join global platform to accelerate the development of and expand the impact of mRNA vaccines and medicines.

RNA

Mobilizing McGill’s mRNA research expertise

With news that Moderna is coming to the Greater Montreal Area, McGill is poised to contribute its established and emerging mRNA research excellence to Canada’s biomanufacturing innovation ecosystem.

RNA

McGill’s Moderna connection

McGill alum Noubar Afeyan is the co-founder and chairman of Moderna and the founder and CEO of Flagship Pioneering.

RNA

mRNA therapies for breast cancer

Targeting mRNA translation to effectively treat metastatic breast cancer.

RNA

The dazzling potential of RNA therapies

McGill’s researchers are exploring the potential and the challenges of RNA-based medicines.

RNA

McGill’s scientific contribution to mRNA biology

An effective mRNA vaccine was made possible by some significant contributions from McGill.

RNA

What is RNA?

RNA plays so many roles, it is the unsung hero of the molecular universe.

RNA